These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7765735)

  • 1. Bacterial aspects associated with the expression of a single-chain antibody fragment in Escherichia coli.
    Somerville JE; Goshorn SC; Fell HP; Darveau RP
    Appl Microbiol Biotechnol; 1994 Dec; 42(4):595-603. PubMed ID: 7765735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of recombinant anti-E-selectin single-chain Fv antibody fragments in stably transfected insect cell lines.
    Mahiouz DL; Aichinger G; Haskard DO; George AJ
    J Immunol Methods; 1998 Mar; 212(2):149-60. PubMed ID: 9672203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of induction conditions on production of a soluble anti-tumor sFv in Escherichia coli.
    Sawyer JR; Schlom J; Kashmiri SV
    Protein Eng; 1994 Nov; 7(11):1401-6. PubMed ID: 7700873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins.
    Dueñas M; Vázquez J; Ayala M; Söderlind E; Ohlin M; Pérez L; Borrebaeck CA; Gavilondo JV
    Biotechniques; 1994 Mar; 16(3):476-7, 480-3. PubMed ID: 7910466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
    McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
    Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain.
    Chen C; Snedecor B; Nishihara JC; Joly JC; McFarland N; Andersen DC; Battersby JE; Champion KM
    Biotechnol Bioeng; 2004 Mar; 85(5):463-74. PubMed ID: 14760686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial expression and characterization of an anti-desipramine single-chain antibody fragment.
    Lin G; Pentel PR; Shelver WL; Keyler DE; Ross CA; Hieda Y; Flickinger MC; Pennell CA; Murtaugh MP
    Int J Immunopharmacol; 1996 Dec; 18(12):729-38. PubMed ID: 9172016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of antigen binding by antibody fragments expressed in the periplasm of Escherichia coli.
    Sawyer JR; Blattner FR
    Protein Eng; 1991 Dec; 4(8):947-53. PubMed ID: 1817258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
    Hayhurst A
    Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting.
    Jung S; Plückthun A
    Protein Eng; 1997 Aug; 10(8):959-66. PubMed ID: 9415446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correctly folded T-cell receptor fragments in the periplasm of Escherichia coli. Influence of folding catalysts.
    Wülfing C; Plückthun A
    J Mol Biol; 1994 Oct; 242(5):655-69. PubMed ID: 7932722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF-alpha) from Escherichia coli caused by the synergistic effects of glycine and triton X-100.
    Yang J; Moyana T; MacKenzie S; Xia Q; Xiang J
    Appl Environ Microbiol; 1998 Aug; 64(8):2869-74. PubMed ID: 9687443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL.
    Jost CR; Titus JA; Kurucz I; Segal DM
    Mol Immunol; 1996 Feb; 33(2):211-9. PubMed ID: 8649442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of factors impeding the production of a single-chain antibody fragment in Escherichia coliby comparing in vivo and in vitro expression.
    Oelschlaeger P; Lange S; Schmitt J; Siemann M; Reuss M; Schmid RD
    Appl Microbiol Biotechnol; 2003 Apr; 61(2):123-32. PubMed ID: 12655454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a recombinant human anti-MUC1 scFv fragment in protease-deficient Escherichia coli mutants.
    Kandilogiannaki M; Koutsoudakis G; Zafiropoulos A; Krambovitis E
    Int J Mol Med; 2001 Jun; 7(6):659-64. PubMed ID: 11351281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
    Huston JS; Levinson D; Mudgett-Hunter M; Tai MS; Novotný J; Margolies MN; Ridge RJ; Bruccoleri RE; Haber E; Crea R
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5879-83. PubMed ID: 3045807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hierarchy of mutations influencing the folding of antibody domains in Escherichia coli.
    Wall JG; Plückthun A
    Protein Eng; 1999 Jul; 12(7):605-11. PubMed ID: 10436087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.
    Furuta M; Uchikawa M; Ueda Y; Yabe T; Taima T; Tsumoto K; Kojima S; Juji T; Kumagai I
    Protein Eng; 1998 Mar; 11(3):233-41. PubMed ID: 9613848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of antibody fragments in Escherichia coli.
    Harrison JS; Keshavarz-Moore E
    Ann N Y Acad Sci; 1996 May; 782():143-58. PubMed ID: 8659891
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.
    Siemers NO; Kerr DE; Yarnold S; Stebbins MR; Vrudhula VM; Hellström I; Hellström KE; Senter PD
    Bioconjug Chem; 1997; 8(4):510-9. PubMed ID: 9258449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.